Boston Scientific Corporation BSX
43.50 USD -0.82 (-1.85%)
At closeNov 3, 2026, 7:59 PM EST
43.52 +0.02 +0.05%
After hours · Nov 3, 7:59 PM ET
43.22 Day range 44.62
39.57 52-week range 105.65
- YTD
- -54.38%
- 1 year
- -55.88%
Analyst view
Consensus: buy
Buy
Price target (mean) 49.60 +14.0% upside
Now 43.50
- Target (low)
- 41.00
- Target (mean)
- 49.60
- Target (high)
- 60.00
Ratings (0m) 31 20 buy · 11 hold · 0 sell
- Strong buy6
- Buy14
- Hold11
- Sell0
- Strong sell0
Recommendation trend
- This month 31
- 1 month ago 31
- 2 months ago 31
- 3 months ago 31
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.77555 | 0.76864 – 0.79 | 0.80 | -3.1% | 5.18B | -2.0% | 24 |
| Next quarter | 0.74429 | 0.70 – 0.78 | 0.80 | -7.0% | 5.06B | -2.7% | 17 |
| Current year | 3.17 | 3.15 – 3.29 | 3.06 | +3.6% | 20.97B | +4.5% | 29 |
| Next year | 3.13 | 3.02 – 3.45 | 3.17 | -1.3% | 21.03B | +0.3% | 29 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | TD Cowen | Downgrade | Buy | Hold |
| Oct 30, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 29, 2026 | Jefferies | Downgrade | Buy | Hold |
| Oct 29, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 29, 2026 | Bernstein | Maintained | Outperform | Outperform |
| Oct 29, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 29, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 29, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Oct 29, 2026 | UBS | Maintained | Buy | Buy |
| Oct 29, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 29, 2026 | Baird | Maintained | Outperform | Outperform |
| Oct 29, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 28, 2026 | Needham | Maintained | Buy | Buy |
| Oct 26, 2026 | Stifel | Maintained | Buy | Buy |
| Oct 14, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 7, 2026 | Barclays | Initiated | — | Equal-Weight |
| Oct 5, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Sep 24, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Sep 21, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Sep 17, 2026 | Citigroup | Downgrade | Buy | Neutral |
| Sep 9, 2026 | BTIG | Maintained | Buy | Buy |
| Aug 25, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Jul 31, 2026 | Argus Research | Downgrade | Buy | Hold |
| Jul 30, 2026 | UBS | Maintained | Buy | Buy |
| Jul 30, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 30, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 30, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 30, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 30, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 30, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
